OSCR Quote, Financials, Valuation and Earnings

Clover Health Investments has a net margin of 9.04% compared to Oscar Health's net margin of -0.28%. Oscar Health's return on equity of 10.83% beat Clover Health Investments's return on equity of -7.67%.

Oscar Health has a consensus price target of $14.99, signalling downside risk potential of -2.32%. On the other hand Clover Health Investments has an analysts' consensus of $4.69 which suggests that it could grow by 55.22%. Given that Clover Health Investments has higher upside potential than Oscar Health, analysts believe Clover Health Investments is more attractive than Oscar Health.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 1.861, suggesting its more volatile than the S&P 500 by 86.075%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend.

Oscar Health quarterly revenues are $3B, which are larger than Clover Health Investments quarterly revenues of $462.3M. Oscar Health's net income of $275.3M is higher than Clover Health Investments's net income of -$1.3M. Notably, Oscar Health's price-to-earnings ratio is 54.82x while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.42x versus 1.00x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 9.04% compared to Oscar Health's net margin of 2.81%. Oscar Health's return on equity of 10.83% beat Centene's return on equity of 12.65%.

Oscar Health has a consensus price target of $14.99, signalling downside risk potential of -2.32%. On the other hand Centene has an analysts' consensus of $54.74 which suggests that it could grow by 79.99%. Given that Centene has higher upside potential than Oscar Health, analysts believe Centene is more attractive than Oscar Health.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.078%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Oscar Health quarterly revenues are $3B, which are smaller than Centene quarterly revenues of $46.6B. Oscar Health's net income of $275.3M is lower than Centene's net income of $1.3B. Notably, Oscar Health's price-to-earnings ratio is 54.82x while Centene's PE ratio is 4.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.42x versus 0.09x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 9.04% compared to Oscar Health's net margin of 4.47%. Oscar Health's return on equity of 10.83% beat Elevance Health's return on equity of 14.03%.

Oscar Health has a consensus price target of $14.99, signalling downside risk potential of -2.32%. On the other hand Elevance Health has an analysts' consensus of $474.91 which suggests that it could grow by 37.84%. Given that Elevance Health has higher upside potential than Oscar Health, analysts believe Elevance Health is more attractive than Oscar Health.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.605, suggesting its less volatile than the S&P 500 by 39.515%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.94% to investors and pays a quarterly dividend of $1.71 per share. Oscar Health pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Oscar Health quarterly revenues are $3B, which are smaller than Elevance Health quarterly revenues of $48.9B. Oscar Health's net income of $275.3M is lower than Elevance Health's net income of $2.2B. Notably, Oscar Health's price-to-earnings ratio is 54.82x while Elevance Health's PE ratio is 13.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.42x versus 0.43x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 9.04% compared to Oscar Health's net margin of 5.74%. Oscar Health's return on equity of 10.83% beat UnitedHealth Group's return on equity of 21.74%.

Oscar Health has a consensus price target of $14.99, signalling downside risk potential of -2.32%. On the other hand UnitedHealth Group has an analysts' consensus of $380.75 which suggests that it could grow by 30.18%. Given that UnitedHealth Group has higher upside potential than Oscar Health, analysts believe UnitedHealth Group is more attractive than Oscar Health.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.449, suggesting its less volatile than the S&P 500 by 55.115%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 2.91% to investors and pays a quarterly dividend of $2.21 per share. Oscar Health pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Oscar Health quarterly revenues are $3B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Oscar Health's net income of $275.3M is lower than UnitedHealth Group's net income of $6.3B. Notably, Oscar Health's price-to-earnings ratio is 54.82x while UnitedHealth Group's PE ratio is 12.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.42x versus 0.66x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.